Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invested in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The Company's portfolio consists of pharmaceutical products with molecules and includes both in-licensed products, such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome as well as products owned (or partially owned) by it, such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > Samira purchased 20,000 shares & 425,000 options expire

<< Previous

Bullboard Posts

Next >>

Post by MrMugsyon Mar 30, 2022 5:24pm

153 Views

Post# 34560675

Samira purchased 20,000 shares & 425,000 options expire

Filed 2022-03-30 16:57 Tx date 2022-03-25	$GUD Knight Therapeutics Inc.	Goodman, Jonathan Ross 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Direct Ownership	Options 52 - Expiration of options	$-2,537,500 -290,000 vol $8.75 each	2,179,548
Filed 2022-03-30 16:52 Tx date 2022-03-25	$GUD Knight Therapeutics Inc.	Khouri, Amal 5 - Senior Officer of Issuer Direct Ownership	Options 52 - Expiration of options	$-1,181,250 -135,000 vol $8.75 each	424,758
Filed 2022-03-30 16:06 Tx date 2022-03-30	$GUD Knight Therapeutics Inc.	Sakhia, Samira 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$103,600 +20,000 vol $5.18 each	117,429